Malignant melanoma, appendageal carcinoma, malignant connective tissue…
Therapeutic procedures · Group T8 — Surgical operations
| Benefit | Amount | Gap to fee |
|---|---|---|
| 85% | $308.65 | $54.45 |
| 75% | $272.35 | $90.75 |
Benefit amounts as published in the schedule, not recalculated.
Fee current from 1 Jul 2026.
(Anaes.) — anaesthesia may be claimed separately in association with this item.
TN.8.22 Removal of Skin Lesions - (Items 31356 to 31388)
The excision of warts and seborrheic keratoses attracts benefits on an attendance basis with the exceptions outlined in TN.8.9 of the explanatory notes to this category. Excision of pre-malignant lesions including solar keratoses where clin… Read the full note
Shown as an excerpt: this note also governs 23 other items in this tool, so it has its own page rather than repeating in full on each one.
TN.8.125 Removal of Skin Lesions - Necessary Excision Diameter - (Items 31356 to 31388)
The necessary excision diameter (or defect size) refers to the lesion size plus a clinically appropriate margin of healthy tissue required with the intent of complete surgical excision. Measurements should be taken prior to excision. Margin… Read the full note
Shown as an excerpt: this note also governs 30 other items in this tool, so it has its own page rather than repeating in full on each one.
| Item number | 31375 |
|---|---|
| Category | 3 — Therapeutic procedures |
| Group | T8 — Surgical operations |
| Subheading | — |
| Item type | S |
| Fee type | N |
| In schedule since | 1 Nov 2016 |
| Fee current from | 1 Jul 2026 |
| GP scope | Yes · tier 1 |